Auf dieser Seite
01PRGO Preis
02Momentaufnahme
03Chart
04Aktiensplits
05Über uns
06Performance
07Bewertung & Kennzahlen
13Dividenden
14Erträge
15Vollständige Fundamentaldaten
16Erklärungen
17Institutionelle Eigentümer (13F)
18Aktivisten & 5%+-Eigentümer
19Unternehmensinsider
20ETF-Besitz
21Konsens
22Peers
23Nachrichten
26Meine Kennzahlen
PRGO Perrigo Company plc Ordinary Shares
NYSE · Pharmaceuticals · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$14,26
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$9,2352-Wochen-Tief
$22,6552-Wochen-Hoch
Marktkapitalisierung (MRQ)
$1.98B
P/E (TTM)
-1.1
EPS (TTM)
$-12.52
Umsatz (TTM)
$4.14B
Ihre Abzeichen
52W-Spanne
$9–$23
Analystenbewertung
BUY
Kursziel
$16
P/E
-1.1
ROE
-49.6%
Nettogewinnmarge
-41.9%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PRGO Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$14.26
Marktkapitalisierung (MRQ)
$1.98B
P/E (TTM)
-1.1
EPS (TTM)
$-12.52
Umsatz (TTM)
$4.14B
Dividendenrendite
8.1%
ROE (TTM)
-49.6%
Verschuldungsgrad (MRQ)
1.3
52W-Spanne
$9–$23
PRGO Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Aktiensplits
| Ex-Datum | Split | Typ |
|---|---|---|
| 26. August 1993 | 2-for-1 | Vorwärts |
Über Perrigo Company plc Ordinary Shares Unternehmensübersicht von Wikipedia
Perrigo ist der weltweit größte Hersteller von OTC-Arzneimitteln mit Sitz in Dublin. Er entstand 2005 durch die Fusion der israelischen Agis und der L. Perrigo Company. Das Unternehmen ist an der New York Stock Exchange und an der Tel Aviv Stock Exchange gelistet und in den Aktienindizes S&P 500 und TA-100 enthalten.
Geschichte
Die L. Perrigo Company wurde 1887 in Allegan, Michigan, Vereinigten Staaten von Luther und Charles Perrigo, die einen Gemischtwarenladen führten gegründet.
1991 hatte Perrigo an der NASDAQ seinen Börsengang.
Am 9. Januar 2008 wurde Galpharm International das 1982 von Graham Leslie gegründete Pharmaunternehmen für 86 Millionen US-Dollar von Perrigo übernommen. Galpharma mit Sitz in Dodworth, Metropolitan Borough of Barnsley, England ist der größte Lieferant von rezeptfreien Medikamenten im Vereinigten Königreich und hatte 2004 bis 2012 die Namensrechte am Galpharm Stadium des englischen Fußballverein Huddersfield Town.
Im Juli 2013 geben Perrigo und Élan bekannt, dass Perrigo Elan für 8,6 Milliarden US-Dollar kauft. Nach der Übernahme verlegte Perrigo seinen Sitz von Allegan nach Dublin.
Im November 2014 wurde die Übernahme von Omega Pharma, die u. a. Nahrungsergänzungsmittel unter der Marke Abtei anbot, bekanntgegeben. Der Kaufpreis soll 3,6 Mrd. Euro betragen haben.
Im April 2015 kündigte der niederländische Konkurrent Mylan an, dass er Perrigo für 28,9 Milliarden US-Dollar übernehmen möchte, zog sein Angebot jedoch im November 2015 wieder zurück, weil ihm nur 40 Prozent der Perrigo-Aktien angeboten wurden.
Perrigo Deutschland
Aus der vormaligen Omega Pharma entstand Ende 2023 Perrigo Deutschland, unter diesem Namen werden seit 2024 auch die früheren Marken Wartner, EllaOne, Granu Fink und Abtei vertrieben.
== Einzelnachweise ==
Quelle: Wikipedia, CC BY-SA 4.0 · Auf Wikipedia ansehen ↗
SektorHealthcare
BranchePharmaceuticals
Mitarbeiter8.100
LandIE
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$4.25B2017-12-31 → 2025-12-31
EPS$-10.292017-12-31 → 2025-12-31
Freier Cashflow$145M2017-12-31 → 2025-12-31
Nettogewinnmarge-41.9%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PRGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -1.15-Jahres-Durchschnitt ≈-103.1 | ≈-103.1 | · | · | |
| P/S (TTM) | 0.55-Jahres-Durchschnitt ≈0.7 | ≈0.7 | · | · | |
| K/B (MRQ) | 0.85-Jahres-Durchschnitt ≈0.8 | ≈0.8 | · | · | |
| Kurs / FCF (TTM) | 16.65-Jahres-Durchschnitt ≈14.0 | ≈14.0 | · | · | |
| Kurs / Cashflow (TTM) | 10.15-Jahres-Durchschnitt ≈9.5 | ≈9.5 | · | · | |
| Kurs / Materieller Buchwert (MRQ) | -1.0 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PRGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 33.3%5-Jahres-Durchschnitt ≈34.8% | ≈34.8% | · | · | |
| Betriebsgewinnmarge (TTM) | -37.7%5-Jahres-Durchschnitt ≈-4.7% | ≈-4.7% | · | · | |
| EBITDA-Marge (TTM) | -29.3%5-Jahres-Durchschnitt ≈3.0% | ≈3.0% | · | · | |
| Vorgewinnmarge (TTM) | -38.9%5-Jahres-Durchschnitt ≈-10.8% | ≈-10.8% | · | · | |
| Nettogewinnmarge (TTM) | -41.9%5-Jahres-Durchschnitt ≈-10.2% | ≈-10.2% | · | · | |
| ROA (TTM) | -19.6%5-Jahres-Durchschnitt ≈-4.7% | ≈-4.7% | · | · | |
| ROE (TTM) | -49.6%5-Jahres-Durchschnitt ≈-11.4% | ≈-11.4% | · | · | |
| ROIC | -18.4%5-Jahres-Durchschnitt ≈-4.9% | ≈-4.9% | · | · |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PRGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 1.35-Jahres-Durchschnitt ≈0.9 | ≈0.9 | · | · | |
| Liquiditätsgrad (MRQ) | 2.35-Jahres-Durchschnitt ≈2.3 | ≈2.3 | · | · | |
| Quick Ratio | 0.65-Jahres-Durchschnitt ≈0.7 | ≈0.7 | · | · | |
| Langfristige Schulden / Eigenkapital (MRQ) | 1.35-Jahres-Durchschnitt ≈0.9 | ≈0.9 | · | · |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | PRGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -2.8%5-Jahres-Durchschnitt ≈0.83% | ≈0.83% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | -1.5%5-Jahres-Durchschnitt ≈1.6% | ≈1.6% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 0.79% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | PRGO | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.55-Jahres-Durchschnitt ≈0.4 | ≈0.4 | · | · | |
| Inventory Turnover (Lagerumschlag) | 2.55-Jahres-Durchschnitt ≈2.6 | ≈2.6 | · | · | |
| Receivables Turnover (Forderungsumschlag) | 6.85-Jahres-Durchschnitt ≈6.5 | ≈6.5 | · | · | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$525.1K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Dividenden Rendite, Ausschüttungsquote, Dividendenhistorie, 5-Jahres-CAGR
Dividendenrendite8.1%
Ausschüttungsquote-11.2%
Annualisierte Auszahlung≈$1.16
5J Div CAGR≈5.2%
Wachstumsphase≈21
| Ex-Datum | Betrag | Währung | Rendite |
|---|---|---|---|
| Aug 28, 2026 | $0,29 | USD | ≈8.0% |
| Mai 29, 2026 | $0,29 | USD | ≈10.5% |
| Mär 2, 2026 | $0,29 | USD | ≈9.4% |
| Aug 29, 2025 | $0,29 | USD | ≈4.8% |
| Mai 30, 2025 | $0,29 | USD | ≈4.2% |
| Mär 7, 2025 | $0,29 | USD | ≈4.0% |
| Nov 29, 2024 | $0,28 | USD | ≈3.9% |
| Aug 30, 2024 | $0,28 | USD | ≈3.8% |
| Mai 31, 2024 | $0,28 | USD | ≈4.0% |
| Mär 7, 2024 | $0,28 | USD | ≈3.7% |
| Nov 30, 2023 | $0,27 | USD | ≈3.6% |
| Aug 31, 2023 | $0,27 | USD | ≈3.1% |
| Jun 1, 2023 | $0,27 | USD | ≈3.3% |
| Mär 9, 2023 | $0,27 | USD | ≈2.9% |
| Dez 1, 2022 | $0,26 | USD | ≈3.2% |
| Sep 1, 2022 | $0,26 | USD | ≈2.8% |
| Jun 2, 2022 | $0,26 | USD | ≈2.5% |
| Feb 25, 2022 | $0,26 | USD | ≈2.7% |
| Dez 2, 2021 | $0,24 | USD | ≈2.7% |
| Sep 2, 2021 | $0,24 | USD | ≈2.3% |
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
13.7%
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $0.50 | $0.35 | 43.2% |
| 31. März 2026 | Mai 12, 2026 | $0.43 | $0.32 | 34.5% |
| 31. Dezember 2025 | $0.79 | $0.80 | -1.4% | |
| 30. September 2025 | $0.80 | $0.77 | 4.0% | |
| 30. Juni 2025 | $0.57 | $0.61 | -5.8% | |
| 31. März 2025 | $0.60 | $0.56 | 7.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $4.25B | $4.37B | $4.66B | $4.45B | $4.14B | $4.09B | $3.87B | $4.73B | $4.95B | $5.28B | · | |
| Cost of Revenue | $2.76B | $2.83B | $2.98B | $3.00B | $2.72B | $2.59B | $2.44B | $2.90B | $2.97B | $3.23B | · | |
| Gross Profit | $1.49B | $1.54B | $1.68B | $1.46B | $1.42B | $1.49B | $1.43B | $1.83B | $1.98B | $2.05B | · | |
| R&D Expense | $95M | $112M | $122M | $123M | $122M | $122M | $119M | $219M | $168M | $184M | · | |
| SG&A Expense | $436M | $468M | $522M | $512M | $482M | $478M | $476M | $436M | $461M | $452M | · | |
| Operating Expenses | $2.62B | $1.43B | $1.53B | $1.38B | $1.01B | $1.23B | $1.26B | $1.59B | $1.38B | $4.05B | · | |
| Operating Income | $-1.12B | $113M | $152M | $79M | $410M | $265M | $175M | $236M | $598M | $-2.00B | · | |
| Other Non-op | $-13M | $900.0K | $10M | $-53M | $-27M | $-16M | $69M | $-6M | $10M | $-23M | · | |
| Pretax Income | $-1.30B | $-81M | $-8M | $-139M | $259M | · | · | $291M | $280M | $-4.85B | · | |
| Income Tax | $104M | $80M | $-4M | $-8M | $390M | $-38M | $-11M | $160M | $160M | $-836M | · | |
| Net Income | $-1.43B | $-172M | $-13M | $-141M | $-69M | $-163M | $146M | $131M | $120M | $-4.01B | · | |
| EPS (Basic) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 | $-1.20 | $1.07 | $0.95 | $0.84 | $-28.01 | · | |
| EPS (Diluted) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 | $-1.19 | $1.07 | $0.95 | $0.84 | $-28.01 | · | |
| Shares (Basic) | 138,500,000 | 137,400,000 | 135,300,000 | 134,500,000 | 133,600,000 | 136,100,000 | 136,000,000 | 137,800,000 | 142,300,000 | 143,300,000 | · | |
| Shares (Diluted) | 138,500,000 | 137,400,000 | 135,300,000 | 134,500,000 | 133,600,000 | 137,200,000 | 136,500,000 | 138,300,000 | 142,600,000 | 143,300,000 | · | |
| EBITDA | $-785M | $439M | $511M | $418M | $723M | $500M | $601M | $660M | $1.04B | $-1.54B | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | $559M | $751M | $601M | $1.86B | $632M | $354M | $551M | $679M | $622M | $418M | |
| Receivables | $613M | $642M | $740M | $697M | $653M | $594M | $1.24B | $1.07B | $1.13B | $1.18B | $1.19B | |
| Inventory | $1.15B | $1.08B | $1.14B | $1.15B | $1.02B | $1.06B | $967M | $878M | $807M | $795M | $899M | |
| Prepaid Expense | $231M | $199M | $201M | $272M | $306M | $182M | $166M | $400M | $203M | $212M | $286M | |
| Current Assets | $2.80B | $2.48B | $2.83B | $2.72B | $3.86B | $3.13B | $2.73B | $2.90B | $2.82B | $2.81B | $2.79B | |
| PP&E (Net) | $899M | $918M | $916M | $926M | $864M | $865M | $774M | $829M | $833M | $870M | $886M | |
| PP&E (Gross) | · | · | · | · | $1.78B | $1.73B | $1.82B | $1.68B | $1.64B | $1.66B | $1.66B | |
| Accum. Depreciation | · | · | · | · | $912M | $861M | $922M | $852M | $805M | $790M | $773M | |
| Goodwill | $2.05B | $3.32B | $3.53B | $3.49B | $3.00B | $3.10B | $3.10B | $3.98B | $4.18B | $4.05B | $5.15B | |
| Intangibles | $4.76B | $4.50B | $5.00B | $5.01B | $3.68B | $3.89B | $4.75B | $4.43B | $4.75B | $4.53B | $5.62B | |
| Other Non-current Assets | $262M | $319M | $335M | $368M | $378M | $347M | $426M | $363M | $410M | $212M | $248M | |
| Total Assets | $8.54B | $9.65B | $10.81B | $11.02B | $10.43B | $11.49B | $11.30B | $10.98B | $11.63B | $13.87B | $19.35B | |
| Accounts Payable | $474M | $495M | $478M | $537M | $411M | $452M | $520M | $475M | $450M | $472M | $556M | |
| Accrued Liabilities | · | $239M | $335M | $250M | $279M | $183M | $229M | $201M | $231M | $263M | $352M | |
| Current Liabilities | $1.01B | $1.04B | $1.59B | $1.11B | $1.59B | $1.38B | $1.34B | $1.54B | $1.44B | $1.84B | $2.55B | |
| Capital Leases | $152M | $154M | $160M | $190M | $147M | $132M | $102M | · | · | · | · | |
| Deferred Tax | $169M | $203M | $262M | $368M | $239M | $276M | $281M | $282M | $322M | $390M | $1.37B | |
| Other Non-current Liabilities | $814M | $499M | $560M | $623M | $530M | $539M | $515M | $443M | $430M | $462M | $346M | |
| Total Liabilities | $5.60B | $5.33B | $6.04B | $6.18B | $5.27B | $5.83B | $5.50B | $5.32B | $5.46B | $7.91B | $9.24B | |
| Long-term Debt | $3.64B | $3.62B | $4.07B | $4.11B | $3.52B | $3.56B | $3.37B | $3.24B | $3.34B | $5.80B | $6.03B | |
| Total Debt | $3.64B | $3.62B | $4.07B | $4.11B | $3.52B | $3.57B | $3.37B | $3.24B | · | $5.80B | · | |
| Common Stock | $6.61B | $6.73B | $6.84B | $6.94B | $7.04B | $7.12B | $7.36B | $7.42B | $7.89B | $8.13B | $8.14B | |
| Retained Earnings | $-3.68B | $-2.25B | $-2.08B | $-2.07B | $-1.93B | $-1.86B | $-1.70B | $-1.84B | $-1.98B | $-2.10B | $1.98B | |
| AOCI | $5M | $-162M | $11M | $-27M | $36M | $395M | $139M | $85M | $253M | $-82M | $-15M | |
| Stockholders' Equity | $2.94B | $4.32B | $4.77B | $4.84B | $5.15B | $5.66B | $5.80B | $5.67B | $6.17B | $5.96B | $10.11B | |
| Liabilities + Equity | $8.54B | $9.65B | $10.81B | $11.02B | $10.43B | $11.49B | $11.30B | $10.98B | $11.63B | $13.87B | $19.35B | |
| Shares Outstanding | 137,600,000 | 136,500,000 | 135,500,000 | 134,700,000 | · | · | · | · | 140,800,000 | 143,400,000 | 143,100,000 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $338M | $326M | $360M | $339M | $312M | $385M | $396M | $424M | $445M | $457M | · | |
| Stock-based Comp | $55M | $64M | $69M | $55M | $60M | $58M | $52M | $38M | $44M | $23M | · | |
| Deferred Tax | $-51M | $10M | $-107M | $-50M | $9M | $-54M | $-44M | $-18M | $-49M | $-991M | · | |
| Amort. of Intangibles | $223M | $228M | $266M | $252M | $210M | $212M | $220M | $334M | $350M | $357M | · | |
| Restructuring | $72M | $110M | $42M | $42M | $17M | $3M | $26M | $21M | $61M | $31M | · | |
| Other Non-cash | $1.22B | $60M | $38M | $125M | $-452M | $341M | $-477M | $-800.0K | $36M | $5.08B | · | |
| Operating Cash Flow | $238M | $363M | $406M | $307M | $156M | $636M | $388M | $593M | $699M | $655M | · | |
| CapEx | $93M | $118M | $102M | $96M | $152M | $170M | $138M | $103M | $89M | $106M | · | |
| Investing Cash Flow | $-75M | $79M | $-78M | $-1.96B | $1.28B | $-188M | $-596M | $-127M | $2.34B | $-175M | · | |
| Debt Issued | $0 | $1.09B | $295M | $1.59B | $0 | $744M | $600M | $431M | $0 | $1.19B | · | |
| Net Debt Issued | $-35M | $-438M | $-30M | $628M | $0 | $154M | $124M | $-52M | $-2.61B | $631M | · | |
| Stock Issued | · | · | · | · | $0 | $0 | $900.0K | $1M | $700.0K | $8M | · | |
| Stock Repurchased | · | · | · | $0 | $0 | $164M | $0 | $400M | $192M | $0 | · | |
| Net Stock Activity | · | · | · | $0 | $0 | $-164M | $900.0K | $-399M | $-191M | $8M | · | |
| Dividends Paid | $159M | $152M | $150M | $142M | $130M | $124M | $112M | $105M | $91M | $83M | · | |
| Financing Cash Flow | $-220M | $-611M | $-187M | $422M | $-179M | $-181M | $2M | $-572M | $-3.00B | $-269M | · | |
| Net Change in Cash | $-25M | $-192M | $151M | $-1.28B | $1.24B | $287M | $-197M | $-128M | $56M | $204M | · | |
| Taxes Paid | $79M | $153M | $97M | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $145M | $245M | $304M | $211M | $4M | $466M | $250M | $490M | $610M | $549M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 35.1% | 35.3% | 36.1% | 32.7% | 34.2% | 35.9% | 36.7% | 38.7% | 40.0% | 38.9% | · | |
| Operating Margin | -26.4% | 2.6% | 3.3% | 1.8% | 9.9% | 2.3% | 4.2% | 5.0% | 12.1% | -37.9% | · | |
| Net Margin | -33.5% | -3.9% | -0.27% | -3.2% | -1.7% | -3.2% | 3.0% | 2.8% | 2.4% | -76.0% | · | |
| Pretax Margin | -30.5% | -1.8% | -0.18% | · | · | · | · | 6.1% | 5.7% | -91.8% | · | |
| EBITDA Margin | -18.4% | 10.0% | 11.0% | 9.4% | 17.5% | 9.9% | 12.4% | 14.0% | 21.1% | -29.2% | · | |
| ROA | -15.7% | -1.7% | -0.12% | -1.3% | -0.63% | -1.4% | 1.3% | 1.2% | · | -24.2% | · | |
| ROE | -38.5% | -3.9% | -0.27% | -3.0% | -1.3% | -2.8% | 2.5% | 2.3% | · | -50.0% | · | |
| ROIC | -18.4% | 2.8% | 0.91% | · | · | · | · | 1.2% | · | -14.1% | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 2.4 | 1.8 | 2.4 | 2.4 | 2.3 | 2.1 | 1.9 | · | 1.5 | · | |
| Quick Ratio | 0.6 | 0.6 | 0.5 | 1.2 | 1.6 | 1.2 | 1.2 | 1.1 | · | 1.0 | · | |
| Debt / Equity | 1.2 | 0.8 | 0.9 | 0.8 | 0.7 | 0.6 | 0.6 | 0.6 | · | 1.0 | · | |
| LT Debt / Equity | 1.2 | 0.8 | 0.8 | 0.8 | 0.6 | 0.6 | 0.6 | 0.5 | · | 0.9 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | 0.4 | · | 0.3 | · | |
| Inventory Turnover | 2.5 | 2.5 | 2.6 | 2.8 | 2.6 | 3.0 | 3.3 | 3.4 | · | 3.8 | · | |
| Receivables Turnover | 6.8 | 6.3 | 6.5 | 6.5 | 6.6 | 4.4 | 4.2 | 4.3 | · | 4.5 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.33 | $31.64 | $35.19 | · | · | · | · | · | · | · | · | |
| Revenue / Share | $30.71 | $31.83 | $34.41 | $33.10 | $30.98 | $37.20 | $35.44 | $34.21 | $34.69 | $36.85 | · | |
| Cash Flow / Share | $1.72 | $2.64 | $3.00 | $2.28 | $1.17 | $4.67 | $2.84 | $4.29 | $4.90 | $4.57 | · | |
| Dividend / Share | $1.16 | $1.10 | $1.09 | $1.04 | $0.96 | $0.90 | $0.82 | $0.76 | $0.64 | $0.58 | · | |
| EPS (TTM) | $-10.29 | $-1.25 | $-0.09 | $-1.04 | $-0.52 | $-1.19 | $1.07 | $0.95 | $0.84 | $-28.01 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -2.8% | -6.1% | 4.6% | 7.6% | 1.2% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | -1.5% | 1.9% | 4.4% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 0.79% | · | · | · | · | · | · | · | · | · | · | |
| Dividends Paid CAGR 5Y | 5.1% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.25B | $4.37B | $4.66B | $4.45B | $4.14B | $4.09B | $3.87B | $4.73B | $4.95B | $5.28B | · | |
| Net Income TTM | $-1.43B | $-172M | $-13M | $-141M | $-69M | $-163M | $146M | $131M | $120M | $-4.01B | · | |
| Market Cap | $1.92B | $3.51B | $4.36B | · | · | · | · | · | · | · | · | |
| P/E | -1.4 | -20.6 | -357.6 | -32.8 | -74.8 | -37.6 | 48.3 | 40.8 | 103.8 | -3.0 | · | |
| P/S | 0.5 | 0.8 | 0.9 | · | · | · | · | · | · | · | · | |
| P/B | 0.7 | 0.8 | 0.9 | · | · | · | · | · | · | · | · | |
| P / Cash Flow | 8.0 | 9.7 | 10.8 | · | · | · | · | · | · | · | · | |
| P / FCF | 13.2 | 14.3 | 14.4 | · | · | · | · | · | · | · | · | |
| Dividend Yield | 8.3% | 4.3% | 3.4% | · | · | · | · | · | · | · | · | |
| Earnings Yield | -73.9% | -4.9% | -0.28% | -3.0% | -1.3% | -2.7% | 2.1% | 2.5% | 0.96% | -33.7% | · | |
| Payout Ratio | -11.2% | -88.8% | -1178.7% | -101.3% | -188.1% | -76.2% | 76.9% | 80.1% | 76.2% | -2.1% | · | |
| Annual Payout | $159M | $152M | $150M | $142M | $130M | $124M | $112M | $105M | $91M | $83M | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.02B | $969M | $1.11B | $1.04B | $1.06B | $1.04B | $1.14B | $1.09B | $1.07B | $1.08B | $1.16B | $1.12B | $1.18B | $1.16B | |
| Cost of Revenue | $709M | $644M | $747M | $666M | $693M | $652M | $752M | $683M | $671M | $724M | $730M | $713M | $768M | $773M | |
| Gross Profit | $314M | $326M | $362M | $377M | $363M | $392M | $386M | $404M | $395M | $358M | $427M | $411M | $414M | $383M | |
| R&D Expense | $24M | $25M | $22M | $25M | $22M | $27M | $28M | $26M | $29M | $29M | $30M | $30M | $31M | $33M | |
| SG&A Expense | $100M | $115M | $116M | $94M | $113M | $112M | $95M | $117M | $126M | $130M | $129M | $126M | $135M | $126M | |
| Operating Expenses | $290M | $698M | $1.65B | $304M | $318M | $345M | $272M | $324M | $421M | $413M | $443M | $349M | $365M | $352M | |
| Operating Income | $24M | $-372M | $-1.29B | $73M | $45M | $47M | $114M | $80M | $-26M | $-55M | $-16M | $62M | $48M | $31M | |
| Other Non-op | $120M | $6M | $-1M | $-10M | $-3M | $400.0K | $600.0K | $4M | $-3M | $-400.0K | $800.0K | $600.0K | $-500.0K | $-4M | |
| Pretax Income | $105M | $-408M | $-1.33B | $22M | $3M | $8M | $70M | $22M | $-74M | $-99M | $-54M | $19M | · | · | |
| Income Tax | $17M | $-19M | $83M | $10M | $4M | $8M | $112M | $39M | $32M | $-103M | $-27M | $4M | $5M | $-2M | |
| Net Income | $74M | $-399M | $-1.42B | $8M | $-8M | $-6M | $-44M | $-21M | $-108M | $2M | $-32M | $14M | $-3M | $-24M | |
| EPS (Basic) | $0.54 | $-2.87 | $-10.23 | $0.05 | $-0.06 | $-0.05 | $-0.32 | $-0.15 | $-0.79 | $0.01 | $-0.23 | $0.10 | $-0.02 | $-0.17 | |
| EPS (Diluted) | $0.53 | $-2.87 | $-10.23 | $0.05 | $-0.06 | $-0.05 | $-0.32 | $-0.15 | $-0.79 | $0.01 | $-0.23 | $0.10 | $-0.02 | $-0.17 | |
| Shares (Basic) | 139,100,000 | 138,700,000 | · | 138,500,000 | 138,200,000 | 137,700,000 | · | 137,500,000 | 137,100,000 | 136,600,000 | · | 135,500,000 | 134,900,000 | · | |
| Shares (Diluted) | 139,600,000 | 138,700,000 | · | 138,900,000 | 138,200,000 | 137,700,000 | · | 137,500,000 | 137,100,000 | 137,600,000 | · | 136,900,000 | 134,900,000 | · | |
| EBITDA | $24M | $-289M | · | $158M | $132M | $127M | · | $80M | $-26M | $26M | · | $62M | $137M | · |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | $432M | $454M | $410M | · | $1.46B | $543M | $658M | · | $598M | $553M | · | |
| Receivables | $710M | $697M | $613M | $644M | $678M | $717M | $642M | $786M | $726M | $780M | · | $738M | $739M | · | |
| Inventory | $1.06B | $1.12B | $1.15B | $1.23B | $1.22B | $1.16B | $1.08B | $1.13B | $1.12B | $1.12B | · | $1.15B | $1.18B | · | |
| Prepaid Expense | $278M | $272M | $231M | $295M | $267M | $229M | $199M | $312M | $282M | $247M | · | $280M | $266M | · | |
| Current Assets | $2.45B | $2.71B | $2.80B | $2.88B | $2.62B | $2.53B | $2.48B | $3.71B | $2.96B | $2.81B | · | $2.77B | $2.74B | · | |
| PP&E (Net) | $849M | $878M | $899M | $903M | $914M | $913M | $918M | $909M | $910M | $911M | $916M | $903M | $919M | $926M | |
| Goodwill | $1.69B | $1.70B | $2.05B | $3.36B | $3.48B | $3.38B | $3.32B | $3.42B | $3.37B | $3.49B | $3.53B | $3.55B | $3.59B | $3.49B | |
| Intangibles | $4.55B | $4.58B | $4.76B | $4.74B | $4.94B | $4.66B | $4.50B | $4.81B | $4.71B | $4.92B | · | $4.85B | $4.94B | · | |
| Other Non-current Assets | $259M | $260M | $262M | $302M | $302M | $301M | $319M | $300M | $316M | $349M | · | $387M | $343M | · | |
| Total Assets | $7.61B | $7.98B | $8.54B | $10.08B | $10.09B | $9.76B | $9.65B | $11.20B | $10.40B | $10.64B | $10.81B | $10.76B | $10.95B | $11.02B | |
| Accounts Payable | $400M | $435M | $474M | $470M | $489M | $502M | $495M | $458M | $472M | $454M | · | $433M | $505M | · | |
| Accrued Liabilities | · | · | · | $363M | $328M | $254M | · | $227M | $218M | $359M | · | $262M | $272M | · | |
| Current Liabilities | $1.05B | $998M | $1.01B | $1.15B | $1.13B | $1.07B | $1.04B | $1.45B | $1.49B | $1.55B | · | $1.01B | $1.09B | · | |
| Capital Leases | $138M | $147M | $152M | $153M | $152M | $150M | $154M | $160M | $164M | $152M | · | $173M | $185M | · | |
| Deferred Tax | $147M | $154M | $169M | $194M | $207M | $189M | $203M | $214M | $212M | $248M | · | $349M | $334M | · | |
| Other Non-current Liabilities | $609M | $712M | $814M | $690M | $673M | $542M | $499M | $660M | $535M | $526M | · | $614M | $638M | · | |
| Total Liabilities | $5.09B | $5.48B | $5.60B | $5.64B | $5.62B | $5.40B | $5.33B | $6.64B | $5.85B | $5.95B | · | $6.02B | $6.12B | · | |
| Long-term Debt | $3.29B | $3.63B | $3.64B | $3.64B | $3.65B | $3.63B | $3.62B | $4.75B | $4.06B | $4.07B | · | $4.09B | $4.10B | · | |
| Total Debt | $3.29B | $3.63B | · | $3.64B | $3.65B | $3.63B | · | $4.75B | $4.06B | $4.07B | · | $4.09B | · | · | |
| Common Stock | $6.54B | $6.58B | $6.61B | $6.64B | $6.66B | $6.69B | $6.73B | $6.76B | $6.79B | $6.80B | · | $6.86B | $6.91B | · | |
| Retained Earnings | $-4.00B | $-4.08B | $-3.68B | $-2.26B | $-2.27B | $-2.26B | $-2.25B | $-2.21B | $-2.19B | $-2.08B | · | $-2.05B | $-2.07B | · | |
| AOCI | $-23M | $-3M | $5M | $70M | $75M | $-70M | $-162M | $10M | $-54M | $-38M | · | $-78M | $-6M | · | |
| Stockholders' Equity | $2.52B | $2.50B | $2.94B | $4.45B | $4.47B | $4.36B | $4.32B | $4.57B | $4.55B | $4.69B | $4.77B | $4.74B | $4.83B | $4.84B | |
| Liabilities + Equity | $7.61B | $7.98B | $8.54B | $10.08B | $10.09B | $9.76B | $9.65B | $11.20B | $10.40B | $10.64B | · | $10.76B | $10.95B | · | |
| Shares Outstanding | 138,700,000 | 138,100,000 | 137,600,000 | 137,600,000 | 137,600,000 | 137,200,000 | 136,500,000 | 136,500,000 | 136,400,000 | 136,300,000 | · | · | · | · |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $96M | $83M | $86M | $85M | $86M | $80M | $80M | $82M | $82M | $81M | $86M | $91M | $89M | $97M | |
| Stock-based Comp | $7M | $14M | $13M | $13M | $17M | $12M | $20M | $6M | $23M | $16M | $11M | $15M | $25M | $8M | |
| Deferred Tax | $-6M | $-13M | $-37M | $-24M | $13M | $-3M | $23M | $-15M | $12M | $-11M | $-119M | $14M | $-10M | $-31M | |
| Amort. of Intangibles | $54M | $54M | $56M | $56M | $57M | $55M | $55M | $58M | $58M | $58M | $63M | $68M | $65M | $74M | |
| Restructuring | $14M | $75M | $13M | $21M | $9M | $29M | $12M | $17M | $37M | $44M | $16M | $16M | $3M | $10M | |
| Other Non-cash | · | $4M | · | · | · | $-323M | · | · | · | $-216M | · | · | $-169M | · | |
| Operating Cash Flow | $83M | $-114M | $175M | $52M | $76M | $-64M | $313M | $42M | $10M | $-1M | $209M | $124M | $19M | $186M | |
| CapEx | $14M | $14M | $27M | $22M | $19M | $26M | $38M | $27M | $28M | $25M | $27M | $32M | $23M | $26M | |
| Investing Cash Flow | $349M | $-12M | $-24M | $-21M | $-4M | $-26M | $-37M | $213M | $-73M | $-24M | $-23M | $-31M | $-20M | $-26M | |
| Debt Issued | $0 | $428M | $0 | $0 | $0 | $0 | $-2M | · | · | · | $295M | $0 | · | $0 | |
| Net Debt Issued | · | $3M | · | · | · | $-9M | · | · | · | $-10M | · | · | · | · | |
| Dividends Paid | $40M | $40M | $40M | $40M | $39M | $41M | $40M | $38M | $38M | $38M | $38M | $39M | $36M | $35M | |
| Financing Cash Flow | $-389M | $-45M | $-54M | $-50M | $-54M | $-62M | $-1.15B | $653M | $-50M | $-60M | $-45M | $-43M | $-51M | $-42M | |
| Net Change in Cash | $40M | $-174M | $100M | $-20M | $37M | $-142M | $-905M | $921M | $-116M | $-93M | $153M | $43M | $-48M | $132M | |
| Free Cash Flow | · | $-127M | · | · | · | $-90M | · | · | · | $-26M | · | · | $-4M | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 30.7% | 33.6% | · | 36.1% | 34.4% | 37.6% | · | 37.2% | 37.0% | 33.1% | · | 36.6% | 35.0% | · | |
| Operating Margin | 2.3% | -38.4% | · | 7.0% | 4.3% | 4.5% | · | 7.4% | -2.5% | -5.1% | · | 5.5% | 4.1% | · | |
| Net Margin | 7.3% | -41.1% | · | 0.72% | -0.80% | -0.61% | · | -1.9% | -10.2% | 0.18% | · | 1.3% | -0.25% | · | |
| Pretax Margin | 10.3% | -42.1% | · | 2.1% | 0.30% | 0.80% | · | 2.0% | · | · | · | · | · | · | |
| EBITDA Margin | 2.3% | -29.8% | · | 15.1% | 12.5% | 12.2% | · | 7.4% | -2.5% | 2.4% | · | 5.5% | 11.6% | · | |
| ROA | 0.84% | -4.5% | · | 0.07% | -0.08% | -0.06% | · | -0.19% | -1.0% | 0.02% | · | 0.13% | · | · | |
| ROE | 2.1% | -11.6% | · | 0.17% | -0.19% | -0.14% | · | -0.45% | -2.3% | 0.04% | · | 0.30% | · | · | |
| ROIC | 0.34% | -5.8% | · | 0.51% | -0.09% | 0.01% | · | -0.70% | · | · | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.3 | 2.7 | · | 2.5 | 2.3 | 2.4 | · | 2.6 | 2.0 | 1.8 | · | 2.7 | · | · | |
| Quick Ratio | 0.7 | 0.7 | · | 0.9 | 1.0 | 1.0 | · | 1.6 | 0.9 | 0.9 | · | 1.3 | · | · | |
| Debt / Equity | 1.3 | 1.5 | · | 0.8 | 0.8 | 0.8 | · | 1.0 | 0.9 | 0.9 | · | 0.9 | · | · | |
| LT Debt / Equity | 1.3 | 1.4 | · | 0.8 | 0.8 | 0.8 | · | 0.9 | 0.8 | 0.8 | · | 0.9 | · | · |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | · | · | |
| Inventory Turnover | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | 0.6 | 0.6 | · | 0.6 | · | · | |
| Receivables Turnover | 1.5 | 1.4 | · | 1.5 | 1.5 | 1.4 | · | 1.4 | 1.4 | 1.4 | · | 1.6 | · | · |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $18.14 | $18.09 | · | $32.31 | $32.50 | $31.81 | · | $33.45 | $33.32 | $34.39 | · | · | · | · | |
| Revenue / Share | $7.33 | $6.99 | · | $7.51 | $7.64 | $7.58 | · | $7.91 | $7.77 | $7.86 | · | $8.21 | $8.76 | · | |
| Cash Flow / Share | · | $-0.82 | · | · | · | $-0.47 | · | · | · | $-0.01 | · | · | $0.14 | · | |
| Cash / Share | · | · | · | $3.14 | $3.30 | $2.99 | · | $10.72 | $3.98 | $4.83 | · | · | · | · | |
| Dividend / Share | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.29 | $0.27 | $0.27 | $0.27 | · | $0.26 | $0.26 | · | |
| EPS (TTM) | $-12.52 | $-13.11 | · | $-0.38 | $-0.58 | $-1.31 | · | $-1.16 | $-0.91 | $-0.06 | · | $-0.03 | $-1.04 | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $4.14B | $4.18B | · | $4.28B | $4.33B | $4.34B | · | $4.39B | $4.43B | $4.56B | · | $4.65B | $4.56B | · | |
| Net Income TTM | $-1.73B | $-1.82B | · | $-52M | $-80M | $-180M | · | $-160M | $-124M | $-8M | · | $-4M | $-141M | · | |
| Market Cap | $1.38B | $1.32B | · | $2.95B | $3.65B | $3.85B | · | $3.50B | $3.50B | $4.39B | · | · | · | · | |
| Enterprise Value | · | · | · | $6.16B | $6.85B | $7.07B | · | $6.79B | $7.02B | $7.79B | · | · | · | · | |
| P/E | -0.8 | -0.7 | · | -56.4 | -45.8 | -21.4 | · | -22.1 | -28.2 | -536.5 | · | -1065.0 | -34.5 | · | |
| P/S | 0.3 | 0.3 | · | 0.7 | 0.8 | 0.9 | · | 0.8 | 0.8 | 1.0 | · | · | · | · | |
| P/B | 0.5 | 0.5 | · | 0.7 | 0.8 | 0.9 | · | 0.8 | 0.8 | 0.9 | · | · | · | · | |
| P / Cash Flow | · | -11.6 | · | · | · | -59.7 | · | · | · | -3133.9 | · | · | · | · | |
| EV / Revenue | · | · | · | 1.4 | 1.6 | 1.6 | · | 1.5 | 1.6 | 1.7 | · | · | · | · | |
| Dividend Yield | 11.6% | 12.0% | · | 5.4% | 4.3% | 4.0% | · | 4.3% | 4.3% | · | · | · | · | · | |
| Earnings Yield | -125.8% | -137.6% | · | -1.8% | -2.2% | -4.7% | · | -4.5% | -3.5% | -0.19% | · | -0.09% | -2.9% | · | |
| Payout Ratio | · | -10.0% | · | · | · | -634.4% | · | · | · | 1880.0% | · | · | -1206.7% | · | |
| Annual Payout | $160M | $159M | · | $159M | $157M | $156M | · | $150M | $152M | · | · | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-04-02 |
|---|---|---|---|---|---|
| Umsatz | $4.25B | $4.37B | $4.66B | $4.45B | · |
| Bruttogewinnmarge % | 35.1% | 35.3% | 36.1% | 32.7% | · |
| Betriebsgewinnmarge % | -26.4% | 2.6% | 3.3% | 1.8% | · |
| Nettoergebnis | $-1.43B | $-172M | $-13M | $-141M | · |
| Verwässerte EPS | $-10.29 | $-1.25 | $-0.09 | $-1.04 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-04-02 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 1.2 | 0.8 | 0.9 | 0.8 | · |
| Liquiditätsgrad | 2.8 | 2.4 | 1.8 | 2.4 | · |
| Quick Ratio | 0.6 | 0.6 | 0.5 | 1.2 | · |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2022-04-02 |
|---|---|---|---|---|---|
| Freier Cashflow | $145M | $245M | $304M | $211M | · |
Institutionelle Eigentümer (13F) 372 Einreicher · $1.8B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
372
Gehaltener Wert
$1.8B
Neue Positionen
72
Geschlossene Positionen
51
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 72 (-4 vs. Vorquartal) | 51 (-8 vs. Vorquartal) | 126 (+20 vs. Vorquartal) | 98 (-13 vs. Vorquartal) | +15.8M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| BlackRock, Inc. | $235.885.493 | 22.703.127 | 12,75% | Aktien |
| VANGUARD GROUP INC | $208.568.497 | 14.983.369 | 11,27% | Aktien |
| NEUBERGER BERMAN GROUP LLC | $110.966.239 | 10.680.100 | 6,00% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $93.984.418 | 9.045.661 | 5,08% | Aktien |
| STATE STREET CORP | $88.664.318 | 8.528.704 | 4,79% | Aktien |
| FULLER & THALER ASSET MANAGEMENT, INC. | $77.906.575 | 7.498.227 | 4,21% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $64.889.893 | 6.245.418 | 3,51% | Aktien |
| Invesco Ltd. | $60.955.034 | 5.866.702 | 3,30% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $56.799.503 | 5.467.098 | 3,07% | Aktien |
| MENORA MIVTACHIM HOLDINGS LTD. | $45.656.964 | 4.394.318 | 2,47% | Aktien |
| Ion Asset Management Ltd. | $39.195.200 | 1.760.000 | 2,12% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $37.643.256 | 3.622.308 | 2,03% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $35.259.152 | 3.480.666 | 1,91% | Aktien |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | $31.421.573 | 3.024.213 | 1,70% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $30.986.419 | 2.982.331 | 1,68% | Aktien |
| EDMOND DE ROTHSCHILD HOLDING S.A. | $27.774.932 | 2.673.237 | 1,50% | Aktien |
| MORGAN STANLEY | $25.103.646 | 2.416.134 | 1,36% | Aktien |
| NORGES BANK | $20.928.483 | 2.014.291 | 1,13% | Aktien |
| AMERICAN CENTURY COMPANIES INC | $19.537.003 | 1.880.366 | 1,06% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $19.490.269 | 1.875.868 | 1,05% | Aktien |
| GOLDMAN SACHS GROUP INC | $18.093.426 | 1.741.427 | 0,98% | Aktien |
| NORTHERN TRUST CORP | $16.964.999 | 1.632.820 | 0,92% | Aktien |
| UBS Group AG | $16.198.945 | 1.559.090 | 0,88% | Aktien |
| Sound Income Strategies, LLC | $16.152.598 | 1.554.629 | 0,87% | Aktien |
| Man Group plc | $15.898.840 | 1.530.206 | 0,86% | Aktien |
| BANK OF AMERICA CORP /DE/ | $15.294.154 | 1.472.007 | 0,83% | Aktien |
| LPL Financial LLC | $14.870.860 | 1.431.267 | 0,80% | Aktien |
| Quantinno Capital Management LP | $14.231.562 | 1.369.736 | 0,77% | Aktien |
| GAMCO INVESTORS, INC. ET AL | $14.168.916 | 1.363.707 | 0,77% | Aktien |
| Cutter Capital Management, LP | $13.445.657 | 479.517 | 0,73% | Aktien |
| CastleKnight Management LP | $13.061.269 | 1.257.100 | 0,71% | Aktien |
| COOKE & BIELER LP | $12.350.271 | 1.188.669 | 0,67% | Aktien |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | $12.029.275 | 1.157.773 | 0,65% | Aktien |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $11.943.263 | 1.149.496 | 0,65% | Aktien |
| Bank of New York Mellon Corp | $11.043.550 | 1.062.902 | 0,60% | Aktien |
| Keeley-Teton Advisors, LLC | $10.534.067 | 375.680 | 0,57% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $9.545.906 | 918.759 | 0,52% | Aktien |
| GABELLI FUNDS LLC | $9.084.590 | 874.359 | 0,49% | Aktien |
| O'Keefe Stevens Advisory, Inc. | $8.682.456 | 835.655 | 0,47% | Aktien |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $8.625.092 | 830.134 | 0,47% | Aktien |
| Blue Door Asset Management, LLC | $8.312.000 | 800.000 | 0,45% | Kaufoption |
| Point72 Asset Management, L.P. | $7.409.867 | 713.173 | 0,40% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $6.948.509 | 668.769 | 0,38% | Aktien |
| ProShare Advisors LLC | $6.569.141 | 632.256 | 0,36% | Aktien |
| NICOLA WEALTH MANAGEMENT LTD. | $6.192.440 | 596.000 | 0,33% | Aktien |
| MOORE CAPITAL MANAGEMENT, LP | $5.890.340 | 566.924 | 0,32% | Aktien |
| Trexquant Investment LP | $5.641.271 | 542.952 | 0,30% | Aktien |
| Empowered Funds, LLC | $5.471.987 | 526.659 | 0,30% | Aktien |
| Caption Management, LLC | $5.195.000 | 500.000 | 0,28% | Kaufoption |
| Caption Management, LLC | $5.195.000 | 500.000 | 0,28% | Verkaufsoption |
Aktivisten & 5%+-Eigentümer 2 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| STARBOARD VALUE LP, STARBOARD VALUE AND OPPORTUNITY MASTER FUND LTD, STARBOARD VALUE AND OPPORTUNITY S LLC, STARBOARD VALUE AND OPPORTUNITY C LP, STARBOARD VALUE R LP, STARBOARD VALUE R GP LLC, STARBOARD VALUE AND OPPORTUNITY MASTER FUND L LP, STARBOARD VALUE L LP, STARBOARD LEADERS KILO LLC, STARBOARD LEADERS FUND LP, STARBOARD LEADERS SELECT III LP, STARBOARD LEADERS SELECT III GP LLC, STARBOARD VALUE A LP, STARBOARD VALUE A GP LLC, STARBOARD VALUE GP LLC, STARBOARD PRINCIPAL CO LP, STARBOARD PRINCIPAL CO GP LLC, JEFFREY C. SMITH, PETER A. FELD ×3 Einreichungen | 16. August 2019 | · | Erste Einreichung | · | SEC |
| Perrigo Company plc (2), Elan Corporation Limited (2), Elan Science One Limited (2) ×2 Einreichungen | 4. Februar 2014 | · | Erste Einreichung | Kapitalstruktur | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 64 Insider · 35 Führungskräfte · 30 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Albert Manzone | Interim President and CEO | 8. Juli 2026 A | 16.353 | 0 | 0 | $0 |
| Murray S Kessler | CEO | 11. Mai 2023 S | 2.668 | 0 | 0 | $0 |
| Uwe Roehrhoff | CEO | 8. März 2018 A | 7.500 | 0 | 0 | $0 |
| John T Hendrickson | CEO | 3. November 2017 M | 8.442 | 0 | 0 | $0 |
| Joseph C Papa | CEO | 26. Februar 2016 A | 118.515 | 0 | 0 | $0 |
| Eduardo Guarita Bezerra | EVP & Chief Financial Officer | 8. Juli 2026 A | 84.700 | 0 | 0 | $0 |
| Raymond Silcock | EVP, Chief Financial Officer | 5. April 2022 M | 59.488 | 0 | 0 | $0 |
| Ronald Winowiecki | CFO | 22. August 2019 S | 6.952 | 0 | 0 | $0 |
| Judy L Brown | EVP, Business Ops & CFO | 25. November 2016 S | 10.007 | 0 | 0 | $0 |
| David Ball | EVP & CBDO | 9. September 2026 M | 11.664 | 0 | 0 | $0 |
| Matthew John Winterman | EVP, Supply, Ops, Strategy | 8. Juli 2026 A | 8.365 | 0 | 0 | $0 |
| Abigail Lennox | EVP and CSO | 8. Juli 2026 A | 4.607 | 0 | 0 | $0 |
| Charles Atkinson | EVP, General Counsel & Sec. | 8. Juli 2026 A | 5.855 | 0 | 0 | $0 |
| Roberto Khoury | EVP and President of CSCI | 8. Juli 2026 A | 14.113 | 0 | 0 | $0 |
| Robert Willis | EVP & CHRO | 8. Juli 2026 A | 50.568 | 0 | 0 | $0 |
| Triona Schmelter | EVP & President CSCA | 6. Juni 2025 A | 6.670 | 0 | 0 | $0 |
| Ronald Craig Janish | EVP, Gbl Ops & SC & CTO | 6. Juni 2025 A | 35.558 | 0 | 0 | $0 |
| Svend Andersen | EVP & President CHCI | 20. August 2024 S | 7.000 | 0 | 0 | $0 |
| Alison Ives | EVP & Chief Scientific Officer | 8. Juli 2024 M | 18.451 | 0 | 0 | $0 |
| Todd W Kingma | Executive VP, General Counsel | 7. Juni 2024 A | 45.269 | 0 | 0 | $0 |
| Grainne Quinn | EVP, Chief Medical Officer | 5. April 2024 A | 21.078 | 0 | 0 | $0 |
| Thomas Farrington | EVP and CIO | 5. April 2024 A | 10.693 | 0 | 0 | $0 |
| Kyle Hanson | EVP & General Counsel | 5. April 2024 A | 11.137 | 0 | 0 | $0 |
| James E Dillard III | EVP & President CSCA | 10. März 2023 S | 25.130 | 0 | 0 | $0 |
| Richard S Sorota | EVP & President CSCA | 5. März 2021 A | 11.161 | 0 | 0 | $0 |
| Sharon Kochan | EVP & President Rx | 5. März 2021 A | 38.748 | 0 | 0 | $0 |
| Jeffrey Needham | EVP, President CHC Americas | 29. Juni 2020 M | 31.191 | 0 | 0 | $0 |
| John Wesolowski | EVP, President Rx | 26. Februar 2019 M | 2.431 | 0 | 0 | $0 |
| Paul Weninger | EVP, Quality Operations | 26. Februar 2019 M | 5.049 | 0 | 0 | $0 |
| James R Michaud | EVP, Chief HR Officer | 8. Oktober 2018 A | · | 0 | 0 | $0 |
| Marc Coucke | Executive VP & GM | 26. Februar 2016 A | · | 0 | 0 | $0 |
| Douglas Boothe | EVP & GM Perrigo Pharma | 26. Februar 2016 A | 803 | 0 | 0 | $0 |
| Jatin Shah | Sr VP & Chief Scientific Offic | 21. August 2015 M | 4.426 | 0 | 0 | $0 |
| Michael Robert Stewart | Sr. VP Global Human Resources | 21. August 2015 M | 1.236 | 0 | 0 | $0 |
| Louis Yu | Executive VP Global Quality | 21. August 2015 M | 6.152 | 0 | 0 | $0 |
| Geoffrey M. Parker | Direktor | 11. September 2026 M | 33.873 | 1 | 0 | $106.350 |
| Bradley Alford | Direktor | 11. September 2026 A | 46.121 | 0 | 0 | $0 |
| Muhammad Omer Gajial | Direktor | 8. Juli 2026 A | · | 0 | 0 | $0 |
| Ahmed Salman Amin | Direktor | 8. Juli 2026 A | · | 0 | 0 | $0 |
| Kevin Francis Egan | Direktor | 14. Mai 2026 M | 3.798 | 0 | 0 | $0 |
| Jonas Samuelson | Direktor | 14. Mai 2026 M | 5.392 | 0 | 0 | $0 |
| Julia M Brown | Direktor | 14. Mai 2026 M | 11.832 | 0 | 0 | $0 |
| Donal O'Connor | Direktor | 14. Mai 2026 M | 34.435 | 0 | 0 | $0 |
| Orlando D Ashford | Direktor | 14. Mai 2026 M | 27.717 | 0 | 0 | $0 |
| Adriana Karaboutis | Direktor | 14. Mai 2025 M | 27.629 | 0 | 0 | $0 |
| Jeffrey B Kindler | Direktor | 14. Mai 2025 M | 10.559 | 0 | 0 | $0 |
| Katherine C. Doyle | Direktor | 13. September 2024 S | 6.009 | 0 | 0 | $0 |
| Erica L Mann | Direktor | 15. Mai 2024 M | 17.458 | 0 | 0 | $0 |
| Theodore R. Samuels II | Direktor | 17. Mai 2022 M | 26.693 | 0 | 0 | $0 |
| Rolf A Classon | Direktor | 2. Dezember 2021 P | 17.442 | 0 | 0 | $0 |
| Smith Jeffrey C | Direktor | 15. Mai 2019 M | 4.809 | 0 | 0 | $0 |
| Gary M Cohen | Direktor | 14. November 2018 M | 20.317 | 0 | 0 | $0 |
| Laurie Brlas | Direktor | 6. Juni 2018 M | 15.329 | 0 | 0 | $0 |
| JANDERNOA MICHAEL J | Direktor | 15. November 2016 G | 142.403 | 0 | 0 | $0 |
| Gary K Kunkle JR | Direktor | 9. September 2016 M | 25.687 | 0 | 0 | $0 |
| Herman Morris JR | Direktor | 8. September 2016 M | 9.352 | 0 | 0 | $0 |
| Shlomo Yanai | Direktor | 19. Mai 2016 A | 443 | 0 | 0 | $0 |
| Ellen Randi Hoffing | Direktor | 19. Mai 2016 A | 9.084 | 0 | 0 | $0 |
| Jacqualyn A Fouse | Direktor | 4. Mai 2016 M | 3.916 | 0 | 0 | $0 |
| Ran Gottfried | Direktor | 19. November 2015 M | 12.728 | 0 | 0 | $0 |
| David T Gibbons | Direktor | 4. November 2015 M | 14.178 | 0 | 0 | $0 |
| Patrick Lockwood-Taylor | · | 5. Juni 2026 M | 123.170 | 0 | 0 | $0 |
| Scott F Jamison | · | 21. August 2015 M | 5.196 | 0 | 0 | $0 |
| Ben-Zion Zilberfarb | · | 18. Dezember 2013 A | 3.197 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 46 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| PEY · Invesco Exchange-Traded Fund Trust | 3,83% | 2.780.929 SH | 1. Oktober 2026 | Täglich |
| PJP · Invesco Exchange-Traded Fund Trust | 3,27% | 1.234.781 SH | 1. Oktober 2026 | Täglich |
| DIV · Global X Funds | 1,37% | 1.064.713 NS | 31. Juli 2026 | N-PORT |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,10% | 133.377 SH | 1. Oktober 2026 | Täglich |
| PILL · Direxion Shares ETF Trust | 1,03% | 21.029 NS | 31. Juli 2026 | N-PORT |
| RZV · Invesco Exchange-Traded Fund Trust | 1,00% | 187.613 SH | 1. Oktober 2026 | Täglich |
| SDIV · Global X Funds | 0,93% | 1.121.000 NS | 31. Juli 2026 | N-PORT |
| IHE · iShares Trust | 0,43% | 512.153 SH | 11. September 2026 | Täglich |
| CVAR · ETF Opportunities Trust | 0,43% | 18.133 NS | 31. Juli 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,28% | 366.080 SH | 1. Oktober 2026 | Täglich |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,15% | 293.607 SH | 19. August 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,13% | 21.318 SH | 1. Oktober 2026 | Täglich |
| VFVA · VANGUARD WELLINGTON FUND | 0,12% | 99.890 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,09% | 122.460 SH | 19. August 2026 | Täglich |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,08% | 482.911 SH | 19. August 2026 | Täglich |
| DFSV · Dimensional ETF Trust | 0,08% | 648.547 NS | 31. Juli 2026 | N-PORT |
| IWM · iShares Trust | 0,06% | 3.606.562 SH | 11. September 2026 | Täglich |
| DFAT · Dimensional ETF Trust | 0,06% | 821.335 NS | 31. Juli 2026 | N-PORT |
| RSSL · Global X Funds | 0,05% | 67.426 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,04% | 810.165 SH | 19. August 2026 | Täglich |
| VBR · VANGUARD INDEX FUNDS | 0,03% | 2.010.523 SH | 19. August 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,02% | 320.378 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,02% | 1.590.918 SH | 19. August 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 3.178.628 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,02% | 415.648 SH | 19. August 2026 | Täglich |
| PRF · Invesco Exchange-Traded Fund Trust | 0,02% | 128.525 SH | 1. Oktober 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 8.428 SH | 11. September 2026 | Täglich |
| VYM · VANGUARD WHITEHALL FUNDS | 0,01% | 546.668 SH | 19. August 2026 | Täglich |
| DXUV · Dimensional ETF Trust | 0,01% | 5.179 NS | 31. Juli 2026 | N-PORT |
| PXF · Invesco Exchange-Traded Fund Trust … | 0,01% | 16.595 SH | 1. Oktober 2026 | Täglich |
| PFM · Invesco Exchange-Traded Fund Trust | 0,01% | 3.941 SH | 1. Oktober 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,01% | 315.315 NS | 31. Juli 2026 | N-PORT |
| NEAR · iShares U.S. ETF Trust | 0,00% | 200.000 SH | 9. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 10.479 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 38.007 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 174.979 SH | 11. September 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 4.401.851 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,00% | 113.746 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 11.350 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,00% | 31.620 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 8.444.789 SH | 10. September 2026 | Täglich |
| IJS · iShares Trust | · | 1.232.185 SH | 8. September 2026 | Täglich |
| IWN · iShares Trust | · | 1.323.382 SH | 11. September 2026 | Täglich |
| ISCB · iShares Trust | · | 5.968 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 29.203 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 195.634 SH | 11. September 2026 | Täglich |
PRGO Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 10 Analysten
KAUF
Median-Ziel
$16.00
+12,2%
2 20,0%
Starker Kauf
4 40,0%
Kauf
4 40,0%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
4 Analysten · 2026-10-03Mittelwert-Ziel $16.50 +15,7%
Jetzt
Aktueller Preis $14.26
Tief$14.00
Mittelwert$16.50
Hoch$20.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026